The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
Open accessAbstract
OBJECTIVE: We report data on 11 patients with neurological symptoms and human immunodeficiency virus (HIV) cerebrospinal fluid (CSF) viremia contrasting with suppressed plasma HIV RNA during receipt of combined antiretroviral therapy. DESIGN: We retrospectively identified instances of central nervous system (CNS) symptoms in patients who had been receiving stable combination antiretroviral therapy. Discordance between plasma and CSF HIV RNA levels was defined by any detectable CSF HIV RNA level >200 copies/mL while plasma levels were <50 copies/mL or by a CSF HIV RNA level that was 1 log greater than the plasma HIV RNA level. RESULTS: Eleven patients had experienced acute or subacute neurological symptoms. All but one patient had CSF pleocytosis and/or elevated protein levels. The median CSF HIV RNA level was 880 copies/mL (range, 558-12,885 copies/mL). Patients had been receiving stable combination antiretroviral therapy for a median of 13 months (range, 10-32 months). Eight of 11 patients had a plasma HIV RNA level <50 copies/mL, and 3 had plasma HIV RNA blips with their CSF HIV RNA level >1 log higher than their plasma HIV RNA level. Resistance-associated mutations were detected in 7 of 8 CSF HIV RNA genotypic strains. The median number of resistance-associated mutations was 6 (range, 2-8) to nucleoside reverse-transcriptase inhibitors and 3 (range, 1-9) to protease inhibitors. One patient had a virus harboring nonnucleoside reverse-transcriptase inhibitor mutations. The median central nervous system penetration-effectiveness (CPE) rank was 2 (range, 1-3), and 5 patients had a CPE 1.5. After antiretroviral therapy optimization based on genotypes and CPE, all patients clinically improved, with normalization of CSF. CONCLUSIONS: Despite successful suppression of plasma viremia with antiretroviral therapy, HIV may replicate in CSF, with development of CSF HIV resistance resulting in acute or subacute neurological manifestations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Letendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 825
The prevalence and incidence of neurocognitive impairment in the HAART era
Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., McArthur, J. C., Collier, A. C., Evans, S. R., & Ellis, R. J. (2007) · AIDS · doi:10.1097/qad.0b013e32828e4e27 · Cited by 619
Marra, C. M., Zhao, Y., Clifford, D. B., Letendre, S., Evans, S., Henry, K., Ellis, R. J., Rodriguez, B., Coombs, R. W., Schifitto, G., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832c4152 · Cited by 347
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
Cysique, L. A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S. P., McCutchan, J. A., Heaton, R. K., & Ellis, R. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab2b3b · Cited by 274
Gorry, P. R., Bristol, G., Zack, J. A., Ritola, K., Swanstrom, R., Birch, C. J., Bell, J. E., Bannert, N., Crawford, K., Wang, H., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10073-10089.2001 · Cited by 265
Peters, P. J., Bhattacharya, J., Hibbitts, S., Dittmar, M. T., Simmons, G., Bell, J., Simmonds, P., & Clapham, P. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6915-6926.2004 · Cited by 183
Ellis, R. J. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.923 · Cited by 155
Highly Active Antiretroviral Therapy Improves Neurocognitive Functioning
Robertson, K. R., Robertson, W. T., Ford, S., Watson, D., Fiscus, S. A., Harp, A. G., & Hall, C. D. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200405010-00003 · Cited by 148
Cunningham, P., Smith, D. G., Satchell, C. S., Cooper, D. A., & Brew, B. J. (2000) · AIDS · doi:10.1097/00002030-200009080-00010 · Cited by 138
Smit, T. K., Brew, B. J., Tourtellotte, W. W., Morgello, S., Gelman, B. B., & Saksena, N. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.10133-10148.2004 · Cited by 137
Schnell, G., Spudich, S., Harrington, P. R., Price, R. W., & Swanstrom, R. I. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000395 · Cited by 136
Spudich, S., Lollo, N., Liegler, T. J., Deeks, S. G., & Price, R. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/508750 · Cited by 94
Tambussi, G., Gori, A., Capiluppi, B., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313810 · Cited by 89
Eggers, C., Hertogs, K., Stürenburg, H.-J., van Lunzen, J., & Stellbrink, H. (2003) · AIDS · doi:10.1097/00002030-200309050-00008 · Cited by 87
Langford, D., Marquie‐Beck, J., de Almeida, S., Lazzaretto, D., Letendre, S. L., Grant, I., McCutchan, J. A., Masliah, E., & Ellis, R. J. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600713932 · Cited by 72
Harrington, P. R., Haas, D. W., Ritola, K., & Swanstrom, R. I. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.7959-7966.2005 · Cited by 61
Cerebrospinal Fluid HIV-1 Infection Usually Responds Well to Antiretroviral Treatment
Mellgren, Å., Antinori, A., Cinque, P. M., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000607 · Cited by 59
Ferrando, S. J., Rabkin, J. G., van Gorp, W. G., Lin, S., & McElhiney, M. C. (2003) · Journal of Neuropsychiatry · doi:10.1176/jnp.15.2.208 · Cited by 52
Wendel, K. A., & McArthur, J. C. (2003) · Clinical Infectious Diseases · doi:10.1086/378300 · Cited by 49
del Saz, S. V., Sued, O. G., Falcó, V., Agüero, F., Casal, M. C., Pumarola, T., Curran, A., Gatell, J. M., Pahissa, A., Miró, J., et al. (2008) · Journal of NeuroVirology · doi:10.1080/13550280802195367 · Cited by 36
Cited by
HIV-associated neurocognitive disorder
Clifford, D. B., & Ances, B. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70269-x · Cited by 670
Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection
Valcour, V., Chalermchai, T., Sailasuta, N., Marovich, M., Lerdlum, S., Suttichom, D., Suwanwela, N. C., Jagodzinski, L., Michael, N., Spudich, S., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis326 · Cited by 522
Gisslén, M., Price, R. W., Andreasson, U., Norgren, N., Nilsson, S., Hagberg, L., Fuchs, D., Spudich, S., Blennow, K., & Zetterberg, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.036 · Cited by 481
Microglial Cells: The Main HIV-1 Reservoir in the Brain
Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00362 · Cited by 368
Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis
Wang, Y., Liu, M., Lu, Q., Farrell, M., Lappin, J. M., Shi, J., Lu, L., & Bao, Y. (2020) · Neurology · doi:10.1212/wnl.0000000000010752 · Cited by 348
Metadata
- Authors
- Canestri, A., Lescure, F., Jaureguiberry, S., Moulignier, A., Amiel, C., Marcelin, A. G., Peytavin, G., Tubiana, R., Pialoux, G., & Katlama, C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-03
- Volume
- 50
- Issue
- 5
- Pages
- 773-778
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2045044146
- Cited by
- 405
- References
- 21
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.